Sleeping Beauty mutagenesis in a mouse medulloblastoma model defines networks that discriminate between human

Laura A Genovesi1, Ching Ging Ng, Melissa J Davis

  • 1Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.

Insights

The Sleeping Beauty (SB) transposon mutagenesis screen identified 56 genes cooperating with sonic hedgehog signaling to initiate medulloblastoma (MB) in mice. These genes revealed common regulatory networks across MB subgroups, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Medulloblastoma (MB) is a pediatric brain tumor driven by complex genetic alterations.
  • Sonic hedgehog (SHH) signaling is a key pathway implicated in MB initiation.
  • Identifying cooperating genes is crucial for understanding MB pathogenesis.

Purpose of the Study:

  • To identify genes that functionally cooperate with sonic hedgehog signaling in MB initiation using Sleeping Beauty (SB) transposon mutagenesis.
  • To define common regulatory networks underlying MB irrespective of molecular subgroup.
  • To uncover potential therapeutic targets for MB.

Main Methods:

  • Sleeping Beauty (SB) transposon mutagenesis combined with Patched1 heterozygous mice (Ptch1(lacZ/+)).
  • Analysis of common insertion sites (CIS) in 85 MB tumors to identify candidate genes.
  • Network analysis and in vivo validation of candidate genes, including Nfia.
  • Mapping of mouse CIS genes to human orthologs and analysis of human MB expression data.

Main Results:

  • SB mutagenesis in Ptch1(lacZ/+) mice accelerated MB formation and decreased survival.
  • Identified 56 candidate genes driving tumorigenesis through 77 common insertion sites.
  • CIS genes accurately clustered human MB samples and revealed common regulatory networks.
  • Confirmed Nfia's role in promoting MB formation.
  • Candidate genes implicated deregulation of apoptosis and translational elongation.

Conclusions:

  • The study identified novel cancer genes cooperating with SHH signaling in MB.
  • Discovered conserved regulatory networks across MB subgroups, suggesting common therapeutic vulnerabilities.
  • Nfia is implicated as a key driver in MB formation.
  • The findings provide insights into MB biology and potential intervention strategies for all clinical subgroups.